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Background: This study aimed to characterize prevalence of anxiety and depressive condi-
tions and uptake of mental health services in an Australian inflammatory bowel disease (IBD) 
outpatient setting.
Methods: Eighty-one IBD patients (39 males, mean age 35 years) attending a tertiary hospital 
IBD outpatient clinic participated in this study. Disease severity was evaluated according to 
the Manitoba Index. Diagnosis of an anxiety or depressive condition was based upon the Mini-
International Neuropsychiatric Interview and the Hospital Anxiety and Depression Scale.
Results: Based on Hospital Anxiety and Depression Scale subscale scores .8 and meeting 
Mini-International Neuropsychiatric Interview criteria, 16 (19.8%) participants had at least 
one anxiety condition, while nine (11.1%) had a depressive disorder present. Active IBD sta-
tus was associated with higher prevalence rates across all anxiety and depressive conditions. 
Generalized anxiety was the most common (12 participants, 14.8%) anxiety condition, and 
major depressive disorder (recurrent) was the most common depressive condition reported (five 
participants, 6.2%). Seventeen participants (21%) reported currently seeking help for mental 
health issues while 12.4% were identified has having at least one psychological condition but 
not seeking treatment.
Conclusion: We conclude that rates of anxiety and depression are high in this cohort, and that 
IBD-focused psychological services should be a key component of any holistic IBD service, 
especially for those identified as having active IBD.
Keywords: inflammatory bowel disease, psychological conditions, disease activity
Introduction
Within the inflammatory bowel disease (IBD) literature, anxiety and depression 
symptoms are commonly identified to be associated with increased disease activity1,2 
and reduced quality of life.1 Research also indicates that ongoing psychological dis-
tress can exacerbate disease activity,3–5 and increase the risk of flare-ups and health 
care costs.4,6,7 Given this, several experts have called for mental health screening and 
targeted treatment of psychological conditions in IBD cohorts.8–10 Despite there being 
approximately 70,000 Australians with IBD,11 limited research has been conducted to 
explore the prevalence of anxiety and mood disorders within this cohort.
Rates or severity of depression and anxiety within the IBD literature have most 
commonly been based upon anxiety and/or depression-specific questionnaires, such 
as the Hospital Anxiety and Depression Scale (HADS).3,8,9,12–18 Within IBD cohorts, 
based on having at least one subscale over 8 (indicating probable diagnosis of anxiety 
or depression), Guthrie et al9 identified a rate of 47.4% in 116 consecutive individuals, 
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while Bennebroek Evertsz et al8 reported a rate of 43% of 231 
adult IBD patients. Using the HADS, Andrews et al19 found 
66% of active IBD patients versus (vs) 37% of non-active IBD 
group had probable anxiety or depression, while Bennebroek 
Evertsz et al8 found that 41.9% with active IBD had scores 
indicative of depression vs 21.1% with non-active IBD.
While reports of anxiety and depression symptom sever-
ity using questionnaires (eg, HADS)20 are quite common 
in the IBD literature, limited research has been undertaken 
to identify the prevalence of anxiety and mood disorders 
within IBD cohorts.19,21–23 Based on interviews using the 
Diagnostic and Statistical Manual III (DSM-III)24 criteria, 
Helzer et al21 found that among 50 ulcerative colitis (UC) 
patients, 26% had a diagnosable condition, with depression 
being the most common (10%). Andrews et al19 interviewed 
80 IBD patients and found that 27% and 26% of Crohn’s 
disease (CD) and UC patients, respectively, had general-
ized anxiety disorder (GAD), major depressive disorder 
(MDD), or dysthymia. Walker et al22 reported that of 40 
IBD patients interviewed, lifetime vs current depression 
were 25% and 3%; panic disorder (PD) lifetime vs current 
was 25% vs 3%; and 35% had GAD while 15% had obses-
sive compulsive disorder (OCD).
Using the composite international diagnostic interview25,26 
with DSM-IV-TR criteria,27 Walker et al23 found that of 351 
IBD patients, 22.2% had at least one mood or anxiety 
condition at 12 months, while 45.3% had a lifetime preva-
lence of at least one anxiety or mood condition. Due to the 
resource-intensive nature of standardized clinical interviews, 
Fuller-Thomson and Sulman28 reported rates of anxiety and/
or depression based upon standardized clinical interview 
questions in a self-report questionnaire format. Based on 
two large Canadian IBD cohorts (n=3,076 [2000–2001]) and 
n=1,438 [1996–1997]), Fuller-Thomson and Sulman reported 
that 16.3% and 14.7% of responders, respectively, met criteria 
for depression (based on DSM-III criteria).
To date, of the studies conducted in Australia, rates of 
depression and anxiety in IBD cohorts have been limited 
to interpretation from symptom-based questionnaire scales 
(eg, HADS).10,13 For example, Knowles et al10 reported 
that based on a sample of 96 patients with Crohn’s disease 
(46% active disease), 44% met the criteria for depression 
and 65% met the criteria for anxiety. To the authors’ knowl-
edge, there are no published data on the prevalence rates 
of anxiety and depressive disorders or rates of engagement 
with mental health services in an Australian IBD outpatient 
cohort. Therefore, the aims of this study were to character-
ize prevalence rates of anxiety and depressive conditions 
and uptake of mental health services in an Australian IBD 
outpatient setting.
Materials and methods
Patients
Eighty-one adults (39 males, 42 females; 56 with Crohn’s 
disease) from the IBD clinic in one teaching hospital were 
studied (45% questionnaire return rate). The average age was 
35.07 years (standard deviation [SD] =12.51). As identified 
55.6% was married or living together with a partner, 43% was 
single, and 2% did not identify relationship status (Table 1). 
Patients’ mean disease duration was 13.46 years (SD =6.35), 
65% had active disease (as defined by the Manitoba Index 
[MI]), and three patients reported having a stoma. Ethical 
approval to conduct this research was attained from the St 
Vincent’s Hospital (Melbourne) and Swinburne University 
of Technology Human Ethics Research Committees.
Disease assessment and questionnaires
MI
The MI29 is a single item assessment of IBD disease  activity. 
Individuals are asked “In the past 6 months my disease has 
been: a) constantly active, giving me symptoms every day, b) 
often active, giving me symptoms most days; c) sometimes 
active, giving me symptoms on some days (for instance 
1–2 days/week); d) occasionally active, giving me symp-
toms 1–2 days/month; e) rarely active, giving me symptoms 
on a few days in the past 6 months; f) I was well in the 
past 6 months, what I consider a remission or absence of 
 symptoms.” The MI has been found to have excellent sensitiv-
ity when compared to standard CD (Harvey-Bradshaw Index) 
and UC (Powell–Tucker Index) disease activity measures and 
test-retest reliability.29
HADS
The HADS20 is a 14-item self-report questionnaire assessing 
levels of anxiety (seven items) and depression (seven items) 
over the past week. Each question is assessed on a 4-point 
Likert Scale: “I feel tense or ‘wound up’” (0= not at all 3= 
most of the time). Consistent with recommendations by 
Bjelland et al30 and research conducted by the authors previ-
ously,10 a cut-off of 8 for each HADS subscale will be used 
to differentiate normal from mild to severe distress.
The Mini-International Neuropsychiatric Interview 
(MINI; Version 6.0.0)
The Mini-International Neuropsychiatric Interview (MINI)31 
is a structured clinical interview used to diagnose  psychiatric 
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Table 1 Sociodemographic and clinical participant characteristics
Characteristics N %
Sex
 Male 39 48.1
 Female 42 51.9
Location born
 Australia 61 75.1
 New Zealand 2 2.5
 Europe (UK) 8 9.8
 Europe (other) 3 3.7
 Asia 2 2.4
 Middle East 3 3.7
 South Africa 1 1.2
 Not identified 1 1.2
Highest education
 Primary school 1 1.2
 Secondary school 34 42
 Certificate/diploma 22 27.1
 Undergraduate degree 18 22.2
 Postgraduate degree 5 6.2
 Not identified 1 1.2
Relationship status
 Married or with partner 45 55.6
 Single 35 43.5
 Not identified 1 1.2
Have children
 Yes 32 39.5
 No 49 60.5
Employment status
 Full-time 32 39.5
 Part-time 8 9.9
 Casual 7 8.6
 Retired 2 2.5
 Home duties 4 4.9
 Student 9 11.1
 Unemployed 10 12.3
 Other 9 11.1
Disease type
 CD 56 69.1
 UC 25 30.9
Stoma
 Yes 3 3.7
 No 78 96.3
Medications
 Aminosalicylates 32 39.5
 Antibiotics 3 3.7
 Corticosteroids 15 18.5
 Immunomodulators 23 28.4
 Biologic 27 33.3
 Not reported 11 13.6
Abbreviations: CD, Crohn’s disease; UC, ulcerative colitis.
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disorders according to DSM-IV-TR27 criteria. Although 
mostly used by clinicians in an interview format, some 
researchers have utilized the MINI in questionnaires in a self-
report format.32 For the purpose of this study, the MINI was 
modified with clinician directed prompts being removed. Prior 
to its use, feedback was attained from experts of mental health 
to ensure these modifications were  appropriate and allowed 
participants to self-complete the MINI. Participants were 
asked to complete all questions relating to MDD (current and 
recurrent), PD, social anxiety disorder (SAD), and GAD.
Procedures
Patients attending an IBD outpatient clinic were invited 
to participate in the study, and where possible, missing 
data were attained from medical records. Inclusion criteria 
were: patients under the care of the hospital IBD outpatient 
service and having been diagnosed with IBD, aged over 
18 years, and able to read and complete the questionnaire. 
The recruitment period was from July 25, 2011 to July 3, 
2012.
Consistent with previous publications by the Manitoba 
group,33–36 active IBD activity was defined as reporting 
symptoms on the MI from “constantly” (a) to “occasion-
ally” (d), and inactive (remission) disease activity “rarely” 
(e) and “well in the last 6 months” (f). Prevalence of 
psychological disorders was evaluated by MINI in a self-
report format.
Results
Sensitivity of MINI diagnosis across 
HADS subscale scores
As identified in Table 2, 84.2% of patients with an anxiety 
score equal to or over 8 on the HADS scale (indicating mild 
to severe distress) were identified with having an anxiety con-
dition according to the MINI scale, while 30.6% of patients 
with an anxiety score equal to or over 8 were categorized as 
not having an anxiety condition. In relation to a diagnosis of 
depression, 42.9% had a depression score equal to or over 8, 
while 15% of those not diagnosed with depression had a 
Table 2 Sensitivity of MINI diagnosis across HADS subscale 
scores
MINI diagnosis HADS-anxiety
,7 8–10 .11
MINI diagnosis–anxiety
 Yes, n (%) 3 (15.8) 5 (26.3) 11 (57.9)
 No, n (%) 43 (69.4) 11 (17.7) 8 (12.9)
      HADS-depression
,7 8–10 .11
MINI diagnosis–depression
 Yes, n (%) 12 (57.1) 1 (4.8) 8 (38.1)
 No, n (%) 51 (85.0) 6 (10.0) 3 (5.0)
Abbreviations: MINI, Mini-International Neuropsychiatric Interview; HADS, 
Hospital Anxiety and Depression Scale.
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Table 3 Mean and standard deviations of study variables by IBD 
type, IBD status, sex, presence of stoma, presence of depressive 
or anxiety disorder, and if currently seeking treatment
Conditions MI HADS-D HADS-A
N Mean (SD) N Mean (SD) N Mean (SD)
Total sample 81 4.16 (1.55) 81 5.08 (4.44) 81 6.95 (4.60)
IBD type
 CD 56 4.16 (1.46) 56 5.35 (4.90) 56 7.21 (4.75)
 UC 25 4.16 (1.75) 25 4.46 (3.20) 25 6.37 (4.26)
 P-value .0.05 .0.05 .0.05
IBD status
 Active 65 4.79 (.96) 65 5.75 (4.55) 65 7.58 (4.67)
 Remission 16 1.62 (.50) 16 2.34 (2.62) 16 4.39 (3.27)
 P-value ,0.001 ,0.01 ,0.05
Mood disorder presenta
 Yes 9 5.33 (.71) 9 13.33 (2.24) 9 13.33 (3.61)
 No 72 4.03 (1.58) 71 4.05 (3.46) 72 6.16 (4.07)
 P-value ,0.05 ,0.001 ,0.001
Anxiety disorder presenta
 Yes 16 4.94 (.93) 16 8.19 (4.81) 16 12.75 (3.04)
 No 65 3.97 (1.61) 65 4.31 (4.03) 65 5.53 (3.71)
 P-value ,0.05 ,0.001 ,0.001
Currently seeking treatment
 Yes 17 4.65 (1.32) 17 9.29 (5.06) 17 9.29 (5.06)
 No 64 4.03 (1.58) 64 6.33 (4.29) 64 6.33 (4.29)
 P-value .0.05 ,0.01 ,0.05
Note: aBased on participates meeting MINI DSM criteria and the associated HADS 
subscale score .8.
Abbreviations: IBD, inflammatory bowel disease; MI, Manitoba Index; MINI, Mini-
International Neuropsychiatric Interview; DSM, Diagnostic and Statistical Manual; 
HADS, Hospital Anxiety and Depression Scale; HADS-A, HADS-anxiety subscale; 
HADS-D, HADS-depression subscale; SD, standard deviation; UC, ulcerative colitis; 
CD, Crohn’s disease.
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
200
Tribbick et al
depression score equal to or over 8. Given that 15.8% and 
57.1% of anxiety and depression conditions, respectively, 
were identified by the HADS subscale as a non-case while 
identified as a case based on the MINI, for the remainder 
of the results, identification of psychological diagnosis will 
be based on 1) MINI criteria only and 2) MINI criteria as 
well as having the relevant HADS subscale score equal to 
or over 8.
Differences in disease activity, anxiety,  
and depression scores
As identified in Table 3, there were no significant differences 
between UC and CD across Manitoba disease severity, and 
anxiety and depression scores. Females were found to have 
significantly higher scores for depression and anxiety. No 
significant differences were found between those with or 
without a stoma. Active disease status was associated with 
significantly higher scores across all the disease severity 
measures and higher rates of depression and anxiety. Higher 
Manitoba disease severity, anxiety, and depression scores 
were found among those patients identified as having a 
mood or anxiety disorder. No significant differences were 
found on Manitoba disease severity between patients seek-
ing mental health support and those not seeking mental 
health support.
Prevalence of having at least one anxiety 
or depressive disorder
Out of 81 patients, 31 (38.3%) were identified as having either 
an anxiety and/or depressive disorder based on MINI criteria; 
however, when considering only those meeting MINI criteria 
and the relevant HADS subscale score over 8, 19 (23.5%) 
participants were identified as having either an anxiety and/
or depressive disorder.
Prevalence of anxiety disorders
As shown in Table 4, 23.5% of participants were found to 
have an anxiety condition, with generalized anxiety being the 
most common (14.8%). Based on the stricter criteria (MINI 
and HADS-anxiety subscale) 16 (19.8%) participants were 
identified as having an anxiety disorder, with GAD being 
the most frequent (n=12; 14.8%) and PD (current) being the 
least frequent (n=1; 1.2%). Of the 16 patients identified to 
be in remission, only two participants (12.5% of patients in 
remission) were found to have an anxiety condition, one had 
GAD while the other had OCD. Active disease activity was 
associated with higher occurrence rates across all anxiety 
conditions. Based upon stricter criteria, GAD was the most 
frequent (n=11; 16.9% of disease active patients), while PD 
(current) was the least frequent anxiety condition (n=1; 1.2% 
of disease active patients).
Of the 64 patients who noted not currently seeking 
help for a mental health issue, eight patients (12.5%) 
were identified as having at least one anxiety disorder 
with GAD being the most common (n=7, 10.9%). Eight 
out of 17 patients who reported currently seeking help for 
a mental health condition were found to have an anxiety 
condition, with GAD being the most frequent (n=5, 29.4%) 
and SAD and OCD conditions were each found in three 
patients (17.6%). PD (current) was the least frequent 
anxiety condition in the cohort seeking help for mental 
health (n=1, 1.5%).
Prevalence of depressive disorders
As shown in Table 5, 25.9% of participants were found to 
have a depressive condition, with dysthymia being the most 
common (9.9%). Based on the stricter criteria (MINI and 
HADS-depression subscale) nine (11.1%) participants were 
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Table 4 Distribution of anxiety conditions by total sample, IBD status, and currently seeking treatment
Conditions Total  
sample
Total  
samplea
IBD statusa Currently seeking 
treatmenta
N % N % N Active N Remission N Yes N No
Panic disorder
 Yes 3 3.7% 3 3.7% 3 4.6% 0 0% 3 17.6% 0 0%
 No 78 96.3% 78 96.3% 62 95.4% 16 100% 14 82.4% 64 100%
Panic disorder (current)  
 Yes 1 1.2% 1 1.2% 1 1.5% 0 0% 1 5.9% 0 0%
 No 80 98.8% 80 98.8% 64 98.5% 16 100% 16 94.1% 64 100%
Panic disorder (lifetime)  
 Yes 2 2.5% 2 2.5% 2 3.1% 0 0% 2 11.8% 0 0%
 No 79 97.5% 79 97.5% 63 96.9% 16 100% 15 88.2% 64 100%
Social anxiety disorder  
 Yes 6 7.4% 6 7.4% 6 9.2% 0 0% 3 17.6% 3 4.7%
 No 75 92.6% 75 92.6% 59 90.8% 16 100% 14 82.4% 61 95.3%
Generalized anxiety disorder  
 Yes 12 14.8% 9 11.1% 11 16.9% 0 0% 5 29.4% 7 10.9%
 No 69 85.2% 72 88.9% 54 83.1% 16 100% 12 70.6% 57 85.2%
Obsessive compulsive disorder  
 Yes 6 7.4% 5 6.2% 5 7.7% 0 0% 3 17.6% 3 4.7%
 No 75 92.6% 76 93.8% 60 92.3% 16 100% 14 82.4% 61 95.3%
Post-traumatic stress disorder  
 Yes 3 3.7% 3 3.7% 3 4.6% 0 0% 2 11.8% 1 1.6%
 No 78 96.3% 78 96.3% 62 95.4% 16 100% 15 88.2% 63 98.4%
Anxiety disorder present  
 Yes 19 23.5% 16 19.8% 16 24.6% 0 0% 8 47.1% 8 12.5%
 No 62 74.1% 65 80.2% 49 75.4% 16 100% 9 52.9% 56 87.5%
Note: aBased on participates meeting MINI DSM criteria and a HADS-anxiety subscale score .8.
Abbreviations: IBD, inflammatory bowel disease; MINI, Mini-International Neuropsychiatric Interview; DSM, Diagnostic and Statistical Manual; HADS, Hospital Anxiety and 
Depression Scale.
with higher  occurrence rates across all depressive conditions. 
Major depressive episode (recurrent) was the most frequent 
(n=5; 7.7% of disease active patients), while dysthymia 
 (current) was the least frequent depressive condition (n=1; 
1.5% of disease active patients).
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Table 5 Distribution of depressive conditions by total sample, IBD status, and currently seeking treatment
Conditions Total  
sample
Total  
samplea
IBD statusa Currently seeking 
treatmenta
N % N % N Active N Remission N Yes N No
Major depressive episode
 Yes 13 16.0% 8 9.9 8 12.3% 0 0% 5 29.4% 3 4.7%
 No 68 84.0% 73 90.1 57 87.7% 16 100% 12 70.6% 61 95.3%
Major depressive episode (current)
 Yes 6 7.4% 3 3.7 3 4.6% 0 0% 3 17.6% 0 0%
 No 75 92.6% 78 96.3 62 95.4% 16 100% 14 82.4% 64 100%
Major depressive episode (recurrent)
 Yes 7 8.6% 5 6.2 5 7.7% 0 0% 2 11.8% 3 4.7%
 No 74 91.4% 76 93.8 60 92.3% 16 100% 15 88.2% 61 95.3%
Dysthymia
 Yes 8 9.9% 1 1.2 1 1.5% 0 0% 0 0% 1 1.6%
 No 73 90.1% 80 98.8 64 98.5% 16 100% 17 100% 63 98.4%
Depressive disorder present
 Yes 21 25.9% 9 11.1 9 13.8% 0 0% 5 29.4% 4 6.3%
 No 60 74.1% 72 88.9 56 86.2% 16 100% 12 70.6% 60 93.8%
Note: aBased on participates meeting MINI DSM criteria and a HADS-depression subscale score .8.
Abbreviations: IBD, inflammatory bowel disease; MINI, Mini-International Neuropsychiatric Interview; DSM, Diagnostic and Statistical Manual; HADS, Hospital Anxiety and 
Depression Scale.
identified as  having a depressive disorder, eight (9.9%) had 
MDD (n=3 had major depressive episode [current]; n=5 had 
major depressive  episode [recurrent]). One patient (1.2%) 
had  dysthymia. None of the 17 patients in remission had a 
depressive  condition. Active disease activity was associated 
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Patients currently seeking mental health 
support
Of the 81 patients, 17 reported seeking help for a current 
mental health issue, seven (41.2%) were male. The average 
length of time reported seeing their mental health expert was 
33.21 months (SD =81.77), with the range being 1 month 
to 26 years. Five out of 17 (29.4%) patients who reported 
currently seeking help for a mental health condition were 
found to have a depressive condition with major depressive 
episode (current) being the most frequent (n=3, 17.6%). Of 
the 64 patients who noted not currently seeking help for a 
mental health issue, ten participants (12.4%) were identi-
fied has having at least one psychological condition. Of the 
ten participants, four (12.5%) patients were identified as hav-
ing a depressive disorder (three patients had MDD-recurrent, 
one patient had dysthymia), five met criteria for GAD, three 
met criteria for SAD, two met criteria for OCD, one met 
criteria for post-traumatic stress disorder, four met criteria 
for MDD, and one met criteria for dysthymia.
Medication use
Fifteen out of 81 (18.5%) patients reported taking psychotro-
pic medications, with ten (66.7%) currently seeking mental 
health support. The average length of time reported being 
on psychotropic medication was 37.2 months (SD =39.59), 
with the range being 3 weeks to 9 years.
Discussion
To the authors’ knowledge, this is the first study to explore 
the prevalence of anxiety and depressive conditions in an 
Australian outpatient cohort. Further, we explored the rates of 
mental-health help seeking behavior. The finding that 19.8% 
and 11.1% of our sample met criteria on the stricter definition 
for an anxiety or mood disorder, respectively, is consistent 
with two population-based studies (USA:37 18.1% and 9.5%; 
New Zealand:38 14.8% and 8%). Our result indicating that 
23.5% had at least one anxiety or depressive disorder is con-
sistent with prevalence rate of 22.2% and 26.0% reported by 
Walker et al23 and Helzer et al,21 respectively. In comparison 
to Walker et al, our prevalence rates were also similar across 
depressive disorders (MDD: 9.1% vs 9.9%; dysthymia: 0.6% 
vs 1.2%) and anxiety disorders (PD: 3.7% vs 3.7%; post-
traumatic stress disorder: 4.0% vs 3.7%). However, it should 
be noted that our study tended to have higher rates of GAD, 
SAD, and OCD compared to the Walker et al’s study (GAD: 
11.1% vs 3.7%; SAD: 7.4% vs 2.6%; OCD: 6.2% vs 1.0%).
Our findings in relation to HADS scores over 8 (ie, 43% 
having anxiety, 22% having depression) is consistent with the 
previous Australian-based HADS studies, who have reported 
a range of 11%–44% for anxiety and from 37%–65% for 
depression.10,13,39 Consistent with previous research,8,19,40 
active IBD status is associated with higher prevalence rates 
across all anxiety and depressive conditions and significantly 
higher scores on the anxiety and depression subscales.
In terms of seeking mental health services, 21.0% of 
participants reported seeking help for a current mental health 
issue, while 12.4% were identified has having at least one 
psychological condition but not seeking treatment. Fifteen 
out of 81 (18.5%) patients reported taking psychotropic 
medications and of these 15, ten participants reported cur-
rently seeking mental health support. These findings suggest 
that while the majority of individuals with a mental health 
condition seek treatment, a minority do not. Further, even 
those who do have support, continue to report criteria meet-
ing a psychological condition. This may suggest that while 
individuals are attaining support, more is needed.
Limitations and future studies
While our f indings are consistent with other IBD 
 prevalence-based studies, a major limitation of this study 
was the use of self-reported data to identify diagnosis rather 
than standardized interviews. However, we sought to vali-
date diagnosis by ensuring that it was also associated with 
a probable diagnosis using a validated frequently used scale 
(HADS) and combined with the MINI which has been used 
previously in self-report format.32 We also note that only 
45% of the questionnaires were returned, so the results will 
only reflect these patients and not the entire hospital IBD 
cohort. It must also be noted that the cohort investigated in 
this study was cross-sectional, English speaking, and rela-
tively small, especially remission sub-group (n=16). Future 
studies could address these limitations by undertaking a 
consecutive IBD sample matched to a general population 
cohort. A final limitation was the utilization of the MI. 
While the index is well validated, it provides a perceived 
measure of disease activity not one based on clinical crite-
ria. Future research could also consider exploring the links 
between psychological conditions within IBD cohorts and 
their potential links to stress, illness perceptions, person-
ality, social support and attachment patterns, and coping 
styles.10,15,34,41,42
Conclusion
To the authors’ knowledge, our study is the first to identify 
the rates of depression and anxiety disorders in an Australian 
IBD outpatient setting. Our results are consistent with those 
found in IBD interview-based prevalence studies conducted 
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in Canada and USA.21,23,28 It is also clear that active IBD is 
associated with higher rates of anxiety and depression disor-
ders also consistent with symptom-based studies conducted 
to date.17,19 Our results also provide evidence that while 
many patients with IBD and a psychological disorder seek 
support, that support may not be sufficient. Further, although 
based on a small sample size, approximately 12% of our 
cohort met criteria for a mental health condition, but were 
not seeking treatment for it. These findings provide further 
evidence for the need of psychological services to be part of 
any IBD service. As a practical starting point, IBD patients, 
especially patients with active disease, should be screened 
for psychological distress.
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